Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing. The CEO's ...
Visitors find China "is not what the media describes," Chinese Consul General in New York Chen Li said in an interview. "It’s ...
As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...
In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC's Squawk on the Street ...
U.S. Senator Steve Daines, second right, leads a delegation of U.S. business leaders from left, Boeing Global Senior VP ...
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
Dr. Albert Bourla, Chairman and CEO, Pfizer speaks onstage during The Wall Street Journal’s 2024 The Future Of Everything Festival at Spring Studios on May 22, 2024 in New York City. - Image ...
President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...
In his previous comments about Pfizer Inc. (NYSE:PFE), Cramer has remained optimistic about the firm’s CEO Dr. Bourla. This time around, he shared how the company is using AI in its operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results